Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2145 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.833 | 48 | 2003 | 2020 | |||||
Malignant neoplasm of breast
|
2154 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.833 | 48 | 2003 | 2020 | |||||
Malignant Neoplasms
|
1441 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.933 | 45 | 2002 | 2019 | |||||
Primary malignant neoplasm
|
1374 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.921 | 38 | 2005 | 2019 | |||||
Neoplasms
|
1571 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.971 | 34 | 2003 | 2018 | |||||
Colorectal Carcinoma
|
1186 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.727 | 22 | 2006 | 2019 | |||||
Carcinoma of lung
|
995 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.850 | 20 | 2000 | 2018 | |||||
Malignant neoplasm of lung
|
1000 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.850 | 20 | 2000 | 2018 | |||||
Primary malignant neoplasm of lung
|
981 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.850 | 20 | 2000 | 2018 | |||||
Liver carcinoma
|
769 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.867 | 15 | 2005 | 2017 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.867 | 15 | 2006 | 2018 | |||||
Cervix carcinoma
|
266 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.929 | 14 | 2002 | 2018 | |||||
cervical cancer
|
257 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.923 | 13 | 2002 | 2018 | |||||
Malignant tumor of cervix
|
245 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.923 | 13 | 2002 | 2018 | |||||
melanoma
|
352 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.833 | 12 | 2006 | 2019 | |||||
Malignant neoplasm of stomach
|
603 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.909 | 11 | 2009 | 2018 | |||||
Stomach Carcinoma
|
616 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.100 | 0.900 | 10 | 2009 | 2015 | |||||
Malignant neoplasm of esophagus
|
169 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.090 | 0.889 | 9 | 2009 | 2015 | |||||
Squamous cell carcinoma
|
197 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.090 | 0.889 | 9 | 1999 | 2018 | |||||
Bladder Neoplasm
|
278 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.080 | 1.000 | 8 | 2010 | 2015 | |||||
Carcinogenesis
|
355 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.080 | 1.000 | 8 | 2008 | 2016 | |||||
Carcinoma of bladder
|
290 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.080 | 1.000 | 8 | 2010 | 2015 | |||||
Endometrial Carcinoma
|
233 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.080 | 0.750 | 8 | 2005 | 2014 | |||||
Esophageal carcinoma
|
170 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.080 | 0.875 | 8 | 2009 | 2015 | |||||
Esophageal Neoplasms
|
160 | 0.426 | 0.800 | 17 | 7676154 | missense variant | G/C;T | snv | 0.67 | 0.080 | 0.875 | 8 | 2009 | 2015 |